{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:11:40Z","timestamp":1787962300743,"version":"build-2784847793"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ECCOJC"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1093\/ecco-jcc\/jjw130","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T04:13:27Z","timestamp":1468296807000},"page":"175-184","source":"Crossref","is-referenced-by-count":55,"title":["Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"11","author":[{"given":"Dennis R.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J.H.","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita H.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J.J.","family":"Derijks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine J.","family":"van Marrewijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf H.","family":"Klungel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk-Jan","family":"Guchelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold G.J.B.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L.M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet M.","family":"Hooymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the TOPIC recruitment team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,9]]},"reference":[{"key":"2017012422200575000_11.2.175.1","doi-asserted-by":"crossref","unstructured":"Prefontaine E Macdonald JK Sutherland LR . Azathioprine or 6-mercaptopurine for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2009:CD000545.","DOI":"10.1002\/14651858.CD000545.pub2"},{"key":"2017012422200575000_11.2.175.2","doi-asserted-by":"crossref","unstructured":"Prefontaine E Sutherland LR Macdonald JK Cepoiu M . Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2009:CD000067.","DOI":"10.1002\/14651858.CD000067.pub2"},{"key":"2017012422200575000_11.2.175.3","doi-asserted-by":"crossref","unstructured":"Timmer A McDonald JW Macdonald JK . Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007:CD000478.","DOI":"10.1002\/14651858.CD000478.pub2"},{"key":"2017012422200575000_11.2.175.4","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200208000-00003"},{"key":"2017012422200575000_11.2.175.5","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21221"},{"key":"2017012422200575000_11.2.175.6","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f28f"},{"key":"2017012422200575000_11.2.175.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01848.x"},{"key":"2017012422200575000_11.2.175.8","doi-asserted-by":"publisher","DOI":"10.2174\/138161210790112773"},{"key":"2017012422200575000_11.2.175.9","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum","year":"1980","journal-title":"Am J Hum Genet"},{"key":"2017012422200575000_11.2.175.10","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.155"},{"key":"2017012422200575000_11.2.175.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70354-4"},{"key":"2017012422200575000_11.2.175.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.06.079"},{"key":"2017012422200575000_11.2.175.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.06.002"},{"key":"2017012422200575000_11.2.175.14","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200406000-00016"},{"key":"2017012422200575000_11.2.175.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70140-5"},{"key":"2017012422200575000_11.2.175.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.3.401"},{"key":"2017012422200575000_11.2.175.17","first-page":"S30","article-title":"Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD","volume":"1","author":"Seidman","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"2017012422200575000_11.2.175.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.05.026"},{"key":"2017012422200575000_11.2.175.19","first-page":"222","article-title":"High TPMT activity as a risk factor for severe myelosuppression during thiopurine therapy","volume":"71","author":"Seinen","year":"2013","journal-title":"Neth J Med"},{"key":"2017012422200575000_11.2.175.20","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.074930"},{"key":"2017012422200575000_11.2.175.21","doi-asserted-by":"crossref","unstructured":"de Jong DJ Derijks LJ Naber AH Hooymans PM Mulder CJ . Safety of thiopurines in the treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl. 2003:69\u201372.","DOI":"10.1080\/00855920310002726"},{"key":"2017012422200575000_11.2.175.22","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91745-V"},{"key":"2017012422200575000_11.2.175.23","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-74-5-580"},{"key":"2017012422200575000_11.2.175.24","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.34"},{"key":"2017012422200575000_11.2.175.25","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200206000-00005"},{"key":"2017012422200575000_11.2.175.26","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00024"},{"key":"2017012422200575000_11.2.175.27","doi-asserted-by":"publisher","DOI":"10.1007\/BF02220605"},{"key":"2017012422200575000_11.2.175.28","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.1.102"},{"key":"2017012422200575000_11.2.175.29","first-page":"5810","article-title":"Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells","volume":"61","author":"Dervieux","year":"2001","journal-title":"Cancer Res"},{"key":"2017012422200575000_11.2.175.30","doi-asserted-by":"publisher","DOI":"10.1159\/000212778"},{"key":"2017012422200575000_11.2.175.31","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.5.656"},{"key":"2017012422200575000_11.2.175.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01511.x"},{"key":"2017012422200575000_11.2.175.33","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283545ae3"},{"key":"2017012422200575000_11.2.175.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.07.004"},{"key":"2017012422200575000_11.2.175.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492"},{"key":"2017012422200575000_11.2.175.36","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12076"},{"key":"2017012422200575000_11.2.175.37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.052"},{"key":"2017012422200575000_11.2.175.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.11.014"},{"key":"2017012422200575000_11.2.175.39","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12226"},{"key":"2017012422200575000_11.2.175.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05084.x"},{"key":"2017012422200575000_11.2.175.41","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000213"},{"key":"2017012422200575000_11.2.175.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04221.x"},{"key":"2017012422200575000_11.2.175.43","first-page":"291","article-title":"Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice","volume":"19","author":"Seinen","year":"2010","journal-title":"J Gastrointestin Liver Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/11\/2\/175\/9938884\/jjw130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T02:30:11Z","timestamp":1503628211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1093\/ecco-jcc\/jjw130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,9]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,24]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1093\/ecco-jcc\/jjw130"],"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw130","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,9]]}}}